1.1 Articolo in rivista

1.1 Articolo in rivista: [37990] Home page tipologia

Sfoglia

Prodotti della tipologia (ordinati per Data di deposito in Decrescente ordine): 11.781 a 11.800 di 37.990

Pharmacokinetics of cisplatin during open and minimally-invasive secondary cytoreductive surgery plus HIPEC in women with platinum-sensitive recurrent ovarian cancer: A prospective study

2019-01-01 Petrillo, M.; Zucchettii, M.; Cianci, S.; Morosi, L.; Ronsini, C.; Colombo, A.; D'Incalci, M.; Scambia, G.; Fagotti, A.

ASO Author Reflections: Surgery and Bevacizumab in Ovarian Cancer

2018-01-01 Petrillo, M.; Scambia, G.; Fagotti, A.

Patterns of Lymph Node Metastases in Apparent Stage I Low-Grade Epithelial Ovarian Cancer: A Multicenter Study

2017-01-01 Minig, L.; Heitz, F.; Cibula, D.; Bakkum-Gamez, J. N.; Germanova, A.; Dowdy, S. C.; Kalogera, E.; Zapardiel, I.; Lindemann, K.; Harter, P.; Scambia, G.; Petrillo, M.; Zorrero, C.; Zanagnolo, V.; Rebollo, J. M. C.; du Bois, A.; Fotopoulou, C.

Role of CTGF in Sensitivity to Hyperthermia in Ovarian and Uterine Cancers

2016-01-01 Hatakeyama, H.; Wu, S. Y.; Lyons, Y. A.; Pradeep, S.; Wang, W.; Huang, Q.; Court, K. A.; Liu, T.; Nie, S.; Rodriguez-Aguayo, C.; Shen, F.; Huang, Y.; Hisamatsu, T.; Mitamura, T.; Jennings, N.; Shim, J.; Dorniak, P. L.; Mangala, L. S.; Petrillo, M.; Petyuk, V. A.; Schepmoes, A. A.; Shukla, A. K.; Torres-Lugo, M.; Lee, J. -S.; Rodland, K. D.; Fagotti, A.; Lopez-Berestein, G.; Li, C.; Sood, A. K.

Does the diagnosis center influence the prognosis of ovarian cancer patients submitted to neoadjuvant chemotherapy?

2015-01-01 Vizzielli, G.; Fanfani, F.; Chiantera, V.; Tortorella, L.; Lucidi, A.; Petrillo, M.; Costantini, B.; Scambia, G.; Fagotti, A.

Positron Emission Tomography–Laparoscopy Based Method in the Prediction of Complete Cytoreduction in Platinum-Sensitive Recurrent Ovarian Cancer

2015-01-01 Fanfani, F.; Monterossi, G.; Fagotti, A.; Gallotta, V.; Costantini, B.; Vizzielli, G.; Petrillo, M.; Carbone, M. V.; Scambia, G.

Sul De syllabarum dinoscenda quantitate libellus di Giorgio Valla (ms. Paris, BNF, lat. 7552)

2021-01-01 Laneri, M.

Laparoscopic radical hysterectomy in cervical cancer as total mesometrial resection (L-TMMR): A multicentric experience

2015-01-01 Chiantera, V.; Vizzielli, G.; Lucidi, A.; Gallotta, V.; Petrillo, M.; Legge, F.; Fagotti, A.; Sehouli, J.; Scambia, G.; Muallem, M. Z.

Profiling cancer gene mutations in longitudinal epithelial ovarian cancer biopsies by targeted next-generation sequencing: A retrospective study

2015-01-01 Beltrame, L.; Di Marino, M.; Fruscio, R.; Calura, E.; Chapman, B.; Clivio, L.; Sina, F.; Mele, C.; Iatropoulos, P.; Grassi, T.; Fotia, V.; Romualdi, C.; Martini, P.; Noris, M.; Paracchini, L.; Craparotta, I.; Petrillo, M.; Milani, R.; Perego, P.; Ravaggi, A.; Zambelli, A.; Ronchetti, E.; D'Incalci, M.; Marchini, S.

Fertility-sparing surgery in ovarian cancer extended beyond the ovaries: A case report and review of the literature

2014-01-01 Petrillo, M.; Legge, F.; Ferrandina, G.; Monterisi, A.; Pedone Anchora, L.; Scambia, G.

Can radicality of surgery be safely modulated on the basis of MRI and PET/CT imaging in locally advanced cervical cancer patients administered preoperative treatment?

2012-01-01 Ferrandina, G.; Petrillo, M.; Restaino, G.; Rufini, V.; Macchia, G.; Carbone, A.; Zannoni, G. F.; Lucidi, A.; D'Angelo, G.; Scambia, G.

Quality of life and emotional distress in early stage and locally advanced cervical cancer patients: A prospective, longitudinal study

2012-01-01 Ferrandina, G.; Mantegna, G.; Petrillo, M.; Fuoco, G.; Venditti, L.; Terzano, S.; Moruzzi, C.; Lorusso, D.; Marcellusi, A.; Scambia, G.

Sox9 and Hif-2α regulate TUBB3 gene expression and affect ovarian cancer aggressiveness

2014-01-01 Raspaglio, G.; Petrillo, M.; Martinelli, E.; Li Puma, D. D.; Mariani, M.; De Donato, M.; Filippetti, F.; Mozzetti, S.; Prislei, S.; Zannoni, G. F.; Scambia, G.; Ferlini, C.

Colonic carcinoma metastatic to the endometrium: The importance of clinical history in averting misdiagnosis as a primary endometrial carcinoma

2011-01-01 Zannoni, G. F.; Vellone, V. G.; Fadda, G.; Petrillo, M.; Scambia, G.

A complete pathological response to treatment in a young patient with locally advanced minimal deviationadenocarcinoma of the uterine cervix undergoing chemoradiation followed by radical surgery

2011-01-01 Ferrandina, G.; Carbone, A.; Macchia, G.; Petrillo, M.; Lucidi, A.; Morganti, A. G.

Completion surgery after concomitant chemoradiation in obese women with locally advanced cervical cancer: Evaluation of toxicity and outcome measures

2013-01-01 Legge, F.; Margariti, P. A.; Lucidi, A.; Macchia, G.; Petrillo, M.; Iannone, V.; Carone, V.; Morganti, A. G.; Scambia, G.; Ferrandina, G.

Cytoreductive surgery plus HIPEC in platinum-sensitive recurrent ovarian cancer patients: A case-control study on survival in patients with two year follow-up

2012-01-01 Fagotti, A.; Costantini, B.; Petrillo, M.; Vizzielli, G.; Fanfani, F.; Margariti, P. A.; Turco, L. C.; Piovano, E.; Scambia, G.

Ovarian cancer patients with "node-positive-only" Stage IIIC disease have a more favorable outcome than Stage IIIA/B

2007-01-01 Ferrandina, G.; Legge, F.; Petrillo, M.; Salutari, V.; Scambia, G.

Polymyxin B-immobilized hemoperfusion and mortality in critically ill adult patients with sepsis/septic shock: a systematic review with meta-analysis and trial sequential analysis

2018-01-01 Fujii, T.; Ganeko, R.; Kataoka, Y.; Furukawa, T. A.; Featherstone, R.; Doi, K.; Vincent, J. -L.; Pasero, D.; Robert, R.; Ronco, C.; Bagshaw, S. M.

Prognostic role of Ca125 response criteria and RECIST criteria: Analysis of results from the MITO-3 phase III trial of gemcitabine versus pegylated liposomal doxorubicin in recurrent ovarian cancer

2008-01-01 Ferrandina, G.; Ludovisi, M.; Corrado, G.; Carone, V.; Petrillo, M.; Scambia, G.

Titolo	Data di pubblicazione	Autore(i)
Pharmacokinetics of cisplatin during open and minimally-invasive secondary cytoreductive surgery plus HIPEC in women with platinum-sensitive recurrent ovarian cancer: A prospective study	1-gen-2019	Petrillo, M.; Zucchettii, M.; Cianci, S.; Morosi, L.; Ronsini, C.; Colombo, A.; D'Incalci, M.; Scambia, G.; Fagotti, A.
ASO Author Reflections: Surgery and Bevacizumab in Ovarian Cancer	1-gen-2018	Petrillo, M.; Scambia, G.; Fagotti, A.
Patterns of Lymph Node Metastases in Apparent Stage I Low-Grade Epithelial Ovarian Cancer: A Multicenter Study	1-gen-2017	Minig, L.; Heitz, F.; Cibula, D.; Bakkum-Gamez, J. N.; Germanova, A.; Dowdy, S. C.; Kalogera, E.; Zapardiel, I.; Lindemann, K.; Harter, P.; Scambia, G.; Petrillo, M.; Zorrero, C.; Zanagnolo, V.; Rebollo, J. M. C.; du Bois, A.; Fotopoulou, C.
Role of CTGF in Sensitivity to Hyperthermia in Ovarian and Uterine Cancers	1-gen-2016	Hatakeyama, H.; Wu, S. Y.; Lyons, Y. A.; Pradeep, S.; Wang, W.; Huang, Q.; Court, K. A.; Liu, T.; Nie, S.; Rodriguez-Aguayo, C.; Shen, F.; Huang, Y.; Hisamatsu, T.; Mitamura, T.; Jennings, N.; Shim, J.; Dorniak, P. L.; Mangala, L. S.; Petrillo, M.; Petyuk, V. A.; Schepmoes, A. A.; Shukla, A. K.; Torres-Lugo, M.; Lee, J. -S.; Rodland, K. D.; Fagotti, A.; Lopez-Berestein, G.; Li, C.; Sood, A. K.
Does the diagnosis center influence the prognosis of ovarian cancer patients submitted to neoadjuvant chemotherapy?	1-gen-2015	Vizzielli, G.; Fanfani, F.; Chiantera, V.; Tortorella, L.; Lucidi, A.; Petrillo, M.; Costantini, B.; Scambia, G.; Fagotti, A.
Positron Emission Tomography–Laparoscopy Based Method in the Prediction of Complete Cytoreduction in Platinum-Sensitive Recurrent Ovarian Cancer	1-gen-2015	Fanfani, F.; Monterossi, G.; Fagotti, A.; Gallotta, V.; Costantini, B.; Vizzielli, G.; Petrillo, M.; Carbone, M. V.; Scambia, G.
Sul De syllabarum dinoscenda quantitate libellus di Giorgio Valla (ms. Paris, BNF, lat. 7552)	1-gen-2021	Laneri, M.
Laparoscopic radical hysterectomy in cervical cancer as total mesometrial resection (L-TMMR): A multicentric experience	1-gen-2015	Chiantera, V.; Vizzielli, G.; Lucidi, A.; Gallotta, V.; Petrillo, M.; Legge, F.; Fagotti, A.; Sehouli, J.; Scambia, G.; Muallem, M. Z.
Profiling cancer gene mutations in longitudinal epithelial ovarian cancer biopsies by targeted next-generation sequencing: A retrospective study	1-gen-2015	Beltrame, L.; Di Marino, M.; Fruscio, R.; Calura, E.; Chapman, B.; Clivio, L.; Sina, F.; Mele, C.; Iatropoulos, P.; Grassi, T.; Fotia, V.; Romualdi, C.; Martini, P.; Noris, M.; Paracchini, L.; Craparotta, I.; Petrillo, M.; Milani, R.; Perego, P.; Ravaggi, A.; Zambelli, A.; Ronchetti, E.; D'Incalci, M.; Marchini, S.
Fertility-sparing surgery in ovarian cancer extended beyond the ovaries: A case report and review of the literature	1-gen-2014	Petrillo, M.; Legge, F.; Ferrandina, G.; Monterisi, A.; Pedone Anchora, L.; Scambia, G.
Can radicality of surgery be safely modulated on the basis of MRI and PET/CT imaging in locally advanced cervical cancer patients administered preoperative treatment?	1-gen-2012	Ferrandina, G.; Petrillo, M.; Restaino, G.; Rufini, V.; Macchia, G.; Carbone, A.; Zannoni, G. F.; Lucidi, A.; D'Angelo, G.; Scambia, G.
Quality of life and emotional distress in early stage and locally advanced cervical cancer patients: A prospective, longitudinal study	1-gen-2012	Ferrandina, G.; Mantegna, G.; Petrillo, M.; Fuoco, G.; Venditti, L.; Terzano, S.; Moruzzi, C.; Lorusso, D.; Marcellusi, A.; Scambia, G.
Sox9 and Hif-2α regulate TUBB3 gene expression and affect ovarian cancer aggressiveness	1-gen-2014	Raspaglio, G.; Petrillo, M.; Martinelli, E.; Li Puma, D. D.; Mariani, M.; De Donato, M.; Filippetti, F.; Mozzetti, S.; Prislei, S.; Zannoni, G. F.; Scambia, G.; Ferlini, C.
Colonic carcinoma metastatic to the endometrium: The importance of clinical history in averting misdiagnosis as a primary endometrial carcinoma	1-gen-2011	Zannoni, G. F.; Vellone, V. G.; Fadda, G.; Petrillo, M.; Scambia, G.
A complete pathological response to treatment in a young patient with locally advanced minimal deviationadenocarcinoma of the uterine cervix undergoing chemoradiation followed by radical surgery	1-gen-2011	Ferrandina, G.; Carbone, A.; Macchia, G.; Petrillo, M.; Lucidi, A.; Morganti, A. G.
Completion surgery after concomitant chemoradiation in obese women with locally advanced cervical cancer: Evaluation of toxicity and outcome measures	1-gen-2013	Legge, F.; Margariti, P. A.; Lucidi, A.; Macchia, G.; Petrillo, M.; Iannone, V.; Carone, V.; Morganti, A. G.; Scambia, G.; Ferrandina, G.
Cytoreductive surgery plus HIPEC in platinum-sensitive recurrent ovarian cancer patients: A case-control study on survival in patients with two year follow-up	1-gen-2012	Fagotti, A.; Costantini, B.; Petrillo, M.; Vizzielli, G.; Fanfani, F.; Margariti, P. A.; Turco, L. C.; Piovano, E.; Scambia, G.
Ovarian cancer patients with "node-positive-only" Stage IIIC disease have a more favorable outcome than Stage IIIA/B	1-gen-2007	Ferrandina, G.; Legge, F.; Petrillo, M.; Salutari, V.; Scambia, G.
Polymyxin B-immobilized hemoperfusion and mortality in critically ill adult patients with sepsis/septic shock: a systematic review with meta-analysis and trial sequential analysis	1-gen-2018	Fujii, T.; Ganeko, R.; Kataoka, Y.; Furukawa, T. A.; Featherstone, R.; Doi, K.; Vincent, J. -L.; Pasero, D.; Robert, R.; Ronco, C.; Bagshaw, S. M.
Prognostic role of Ca125 response criteria and RECIST criteria: Analysis of results from the MITO-3 phase III trial of gemcitabine versus pegylated liposomal doxorubicin in recurrent ovarian cancer	1-gen-2008	Ferrandina, G.; Ludovisi, M.; Corrado, G.; Carone, V.; Petrillo, M.; Scambia, G.

Prodotti della tipologia (ordinati per Data di deposito in Decrescente ordine): 11.781 a 11.800 di 37.990

Legenda icone

file ad accesso aperto
file disponibili sulla rete interna
file disponibili agli utenti autorizzati
file disponibili solo agli amministratori
file sotto embargo
nessun file disponibile

Scopri

Accesso al fulltext

no fulltext33874
open3619
reserved293
restricted136
partially open66
mixed2